fig1

Rethinking miRNAs in MSC-sEV therapeutics: implications for manufacture, mechanism of action, and development of robust potency CQAs

Figure 1. Diagrammatic summary: advantages of MSC-sEVs over MSCs (Figure was created with AI-assisted technologies). MSC: Mesenchymal stem cell; sEV: small extracellular vesicle.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/